摘要:
A hybrid vehicle includes a battery system, an internal combustion engine, a first motor/generator, a second motor/generator, and an engageable clutch assembly. The engageable clutch assembly is disposed between the internal combustion engine and the first motor/generator. When engaged, the engageable clutch assembly couples the rotor spindle of the second motor/generator with the hollow rotor shaft of the first motor/generator. The engageable clutch assembly may also operate in a first mechanical mode that selectively engages and disengages the internal combustion engine from the second motor/generator, or operate in a second mechanical mode that dampens shock between the internal combustion engine and the first motor/generator when the international combustion engine operates at a rotational speed that is different than a rotational of the first motor/generator.
摘要:
This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
摘要:
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
摘要:
The present invention relates to a method of producing a catalyst or pre-catalyst suitable for assisting in the production of alkenyl alkanoates. The method includes contacting a modifier precursor to a support material to form a modified support material. One or more catalytic component precursors (palladium or gold) may be contacted to the modified support material. The atomic ratio of gold to palladium is preferably in the range of about 0.3 to about 0.90. The support materials with the catalytic component may then be reduced using a reducing environment. A composition for catalyzing the production of an alkenyl alkanoates including a modified support material with palladium and gold is also included within the invention. Catalysts of the present invention may be used to produce alkenyl alkanoates in general and vinyl acetate in particular and are useful to produce low EA/VA ratios while maintaining or improving CO2 selectivity.
摘要:
The invention provide a process for producing directly mixed linear alpha-alcohols having 1 to 18 carbon atoms from synthesis gas comprising hydrogen and carbon monoxide, comprising the step of reacting hydrogen and carbon monoxide over a catalyst to produce mixed linear alpha-alcohols having 1 to 18 carbon atoms and hydrocarbons having 1 to 25 carbon atoms through Fischer-Tropsch process in one step in a reactor, wherein: the mole ratio of hydrogen to carbon monoxide is within the range of 1 to 3; the catalyst is an activated carbon supported cobalt based catalyst; the reactor is a fixed bed reactor, a slurry reactor or a fluid reactor; the reaction is carried out under specific conditions.
摘要:
The invention provide a process for producing directly mixed linear alpha-alcohols having 1 to 18 carbon atoms from synthesis gas comprising hydrogen and carbon monoxide, comprising the step of reacting hydrogen and carbon monoxide over a catalyst to produce mixed linear alpha-alcohols having 1 to 18 carbon atoms and hydrocarbons having 1 to 25 carbon atoms through Fischer-Tropsch process in one step in a reactor, wherein: the mole ratio of hydrogen to carbon monoxide is within the range of 1 to 3; the catalyst is an activated carbon supported cobalt based catalyst; the reactor is a fixed bed reactor, a slurry reactor or a fluid reactor; the reaction is carried out under specific conditions.
摘要:
The invention provides an activated carbon supported cobalt based catalyst for directly converting of synthesis gas to mixed linear alpha-alcohols and paraffins, comprising cobalt, an activated carbon carrier, a metal promoter which is at least one selected from the group consisting of a zirconium component, a lanthanum component, a cerium component, a chromium component, a vanadium component, a titanium component, a manganese component, a rhenium component, a potassium component, a ruthenium component, a magnesium component and a mixture thereof, wherein the cobalt and the promoter are deposited on the activated carbon carrier or substantially uniformly dispersed therein, and the metal promoter is present in the form of a metal, an oxide or a combination thereof.
摘要:
This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
摘要:
The present invention addresses at least four different aspects relating to catalyst structure, methods of making those catalysts and methods of using those catalysts for making alkenyl alkanoates. Separately or together in combination, the various aspects of the invention are directed at improving the production of alkenyl alkanoates and VA in particular, including reduction of by-products and improved production efficiency. A first aspect of the present invention pertains to a unique palladium/gold catalyst or pre-catalyst (optionally calcined) that includes rhodium or another metal. A second aspect pertains to a palladium/gold catalyst or pre-catalyst that is based on a layered support material where one layer of the support material is substantially free of catalytic components. A third aspect pertains to a palladium/gold catalyst or pre-catalyst on a zirconia containing support material. A fourth aspect pertains to a palladium/gold catalyst or pre-catalyst that is produced from substantially chloride free catalytic components.
摘要:
This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with diketo piperazine and piperadine derivatives that possess unique antiviral activity. More particularly, the present disclosure relates to compounds useful for the treatment of HIV and AIDS.